Triton Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-5,935
Closed -$533K – 118
2021
Q1
$533K Buy
+5,935
New +$589K 0.36% 52

Other funds holding ARKG

Triton Wealth Management's ARKG Position: Q2 2021 in Review

Triton Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 5,935 shares — an estimated $533K sold.

Triton Wealth Management first reported a position in ARKG in Q1 2021 and held it in 1 quarter. The position peaked at $533K in Q1 2021. 514 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • Triton Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
  • Triton Wealth Management sold 5,935 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $533K.
  • Triton Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 1 quarter.
  • Triton Wealth Management's ARK Genomic Revolution ETF position peaked at $533K in Q1 2021.
  • 514 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on Triton Wealth Management's 13F filing for Q2 2021, filed 13 Aug 2021.